Makya - SaaS Platform Software
Makya is the first user-friendly SaaS platform for AI-driven de novo drug design focused on Multi-Parametric Optimization (MPO).
Auto machine learning technology
Makya automatically proposes new molecules for your lead optimization project in a few hours!
In just a few clicks, access the power of AI through Makya’s user friendly interface:
- Upload your project data
- Define your target product profile
- Review, assess and select the ideas designed by Makya's AI engine
Makya is connected to Spaya, our AI-driven synthetic planning technology.
All promising ideas proposed by Makya are scored by Spaya to make sure you will be able to easily synthesize your next target compound.
Makya can be operated in Python and can be easily interfaced within your existing in-house machine learning workflows. We call Makya’s Python UI “Kaya”.
Makya is accessible as a SaaS platform running in Iktos’ private infrastructure, it can also easily be deployed in your virtual private cloud (AWS, Google cloud, Microsoft Azure) or on your premises.
Who’s behind Makya?
We are Iktos. A start-up company specializing in the development of proprietary artificial intelligence technologies and software forligand-basedandstructure-basedde novodrug design focusing on multi parametric optimization.
Ourde novodesign algorithm is based on deep generative models with reinforcement learning. It designs novel and easy to make compounds, optimized to meet a given multi-objective blueprint, with unprecedented speed, performance, and diversity.